title: The hype cycle for soluble urokinase receptor in FSGS: passing the trough of disillusionment?
authors.affiliation: Department of Nephrology, UZ Leuven, Leuven, Belgium; andDepartment of Immunology and Microbiology, KU Leuven, Leuven, Belgium bjorn.meijers@uzleuven.be.
authors.forename: Björn
authors.initials: B
authors.lastname: Meijers
authors.affiliation: Department of Nephrology, UZ Leuven, Leuven, Belgium; andDepartment of Immunology and Microbiology, KU Leuven, Leuven, Belgium.
authors.forename: Ben
authors.initials: B
authors.lastname: Sprangers
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D055293:Receptors, Urokinase Plasminogen Activator / Q000097:blood*
chemical_list: D000893:Anti-Inflammatory Agents; D055293:Receptors, Urokinase Plasminogen Activator; D011241:Prednisone
keywords: FSGS; GFR; urokinase